SEC FORM 4
$1,053,814.30
Oric Pharmaceuticals, Inc. (ORIC)
Sale of 77,000 shares at $13.6859 per share.
Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S
Traded Aug 26, 2026 · Disclosed Aug 28, 2026
Source: SEC Form 4 · 0001695028-26-000006 · filed 2026-08-28 · View filing →